Inclination Towards Generic Drugs to Drive the Rosacea Treatment Market
As per a report published on XploreMR, the global rosacea treatment market will grow at a substantial rate between 2020 and 2030. The factors contributing to the escalation of the market include advanced formulations, proactive initiatives on the part of governments, and high incidences of disease.
Research states that rosacea does affect over 400 million people across the globe, still stays underdiagnosed. Fair-skinned people (women, in particular), are found to be more prone to rosacea. At times, it is misdiagnosed as “acne” due too similar symptoms.
On the positive side, the rosacea market is expected to witness generic penetration of the first order. This could be credited to multiple off-page usage of the medicines along with patent expiries. As of now, azelaic acid, benzoyl peroxide (the ones used for treating acne) are being used for treating rosacea. Combination therapies are being emphasized on to give better results. Till date, oral or topical treatments have been administered.
The antibiotics used for treating rosacea include tetracycline, minocycline, doxycycline, clarithromycin, clindamycin, erythromycin, and metronidazole as the first line of therapy. Cytokines are suppressed by making use of immunosuppressants like tacrolimus. This, in turn, helps in reducing itching and inflammation.
Rosacea-related erythema is treated by Rhofade and Mirvaso. These alpha agonists are expected to take the rosacea treatment market by storm in the upcoming period. The other revenue generators include Noritate, Soolantra, Finacea, and Oracea.
Oral or Topical?
Topical drugs have been having an upper hand, accounting for over two-third market. A combination of topical and oral drugs is likely to be used in future for more effective results. However, ocular rosacea calls for oral administration.
North America alone holds more than 50% of market share and is expected to continue with the winning streak in the forecast period. The reasons include increasing drug approvals, getting exposed to the environmental triggers, precise diagnosis, novel drug development, and increasing awareness of consumers.
Europe stands second as it is home to more fair-skinned people. The cool climate over there also causes skin to get drier, thereby drawing more people towards rosacea. Countries like Denmark and Belgium are into more investment in healthcare, followed by Germany. The other countries are also following suit. These factors are bound to put Europe at the second-most position in the rosacea market.
Asia-Pacific, Latin America, MEA will pick up pace soon as awareness regarding rosacea is bound to reach these economies in full swing in the next few years. With penetration of generic drugs, the market could be open for these economies as well. For patented drugs, restrictions do apply in terms of outreach. With the above-mentioned economies also joining the bandwagon, things are brighter rosacea treatment market in future.
The outbreak of Covid-19 has put the research activities related to rosacea at the backburner for the time being. Healthcare personnel are devoting more time towards checking the spread of Covid-19. Devising vaccines in this regard is also on the anvil (though Russia claims to have come up with one).
The scenario mentioned above is bound to continue till the end of 2020. The year 2021 is expected to come with new hopes. In other words, normalcy is expected to get restored. This normalcy is likely to ask for more of generic drugs/medications for rosacea, as it would certainly take time for the economy worldwide to be back into action. So, frugal spending would be the need of the hour.
The key players in the rosacea treatment market include Bausch Heaalth Companies, Inc., Bayer Schering AG, Allergan Plc, Nestle S.A.
A recent market study published by XploreMR – “Rosacea Therapeutics Market: Global Industry Analysis 2013-2017 & Forecast 2018-2026” consists a comprehensive assessment of the most important market dynamics. On conducting a thorough research on the historic as well as current growth parameters of the Rosacea therapeutics market, growth prospects of the market are obtained with maximum precision. The report features unique and salient factors that may make a huge impact on the development of the Rosacea therapeutics market during the forecast period.
It can help market players to modify their manufacturing and marketing strategies to envisage maximum growth in the Rosacea therapeutics market in the upcoming years. The report provides detailed information about the current and future growth prospects of the Rosacea therapeutics market in the most comprehensive way for the better understanding of readers.
Chapter 1 – Executive Summary
The report commences with the executive summary of the Rosacea therapeutics market report, which includes the summary of key findings and key statistics of the market. It also includes the market value (US$ million) estimates of the leading segments of the Rosacea therapeutics market.
Chapter 2 – Market Overview
Readers can find detailed taxonomy and the definition of the Rosacea therapeutics market in this chapter, which helps readers to understand the basic information about the Rosacea therapeutics market dynamics, supply chain, cost structure, pricing analysis, list of key distributor and suppliers, list of key market participants included in the report.
Chapter 3 – Global Rosacea Therapeutics Market Analysis 2013-2017 & Forecast 2018-2026, By Drug Class
Based on the drug class, the Rosacea therapeutics market is segmented into antimicrobials, alpha agonists, retinoid and others. In this chapter, readers can find information about key trends and developments in the Rosacea therapeutics market and market attractive analysis based on the antimicrobials, alpha agonists, retinoid and others. In this chapter, readers can find information about key trends and developments in the Rosacea therapeutics market and market attractive analysis based on the drug class for each region.
Chapter 4 – Global Rosacea Therapeutics Market Analysis 2013-2017 & Forecast 2018-2026, By Distribution Channel
Based on the distribution channel, the rosacea therapeutics market is segmented into institutional sales, and retail sales. In this chapter, readers can find information about key trends and developments in the Rosacea therapeutics market and market attractive analysis based on distribution channel. In this chapter, readers can find information about key trends and developments in the Rosacea therapeutics market and market attractive analysis based on the distribution channel for each region.
Chapter 5 – Global Rosacea Therapeutics Market Analysis 2013-2017 & Forecast 2018-2026, By Region
This chapter explains how the Rosacea therapeutics market will grow across various geographic regions, such as North America, Latin America, Europe, Asia-Pacific, and the Middle East & Africa (MEA).
Chapter 6 – North America Rosacea Therapeutics Market Analysis 2013-2017 & Forecast 2018-2026
This chapter includes detailed analysis of the growth of the North America Rosacea Therapeutics market along with the country-wise assessment including the U.S. and Canada. readers can also find regional trends, regulations, and market growth based on drug class, distribution channel and country of Rosacea therapeutics in the North American region.
Chapter 7 – Latin America Rosacea Therapeutics Market Analysis 2013-2017 & Forecast 2018-2026
Readers can find detailed information about factors such as, pricing analysis, and regional trends that are impacting the growth of the Latin America Rosacea therapeutics market. This chapter also includes the growth prospects of the Rosacea therapeutics market in the Latin America region.
Chapter 8 – Europe Rosacea Therapeutics Market Analysis 2013-2017 & Forecast 2018-2026
Important growth prospects of the Rosacea therapeutics market based on its drug class, distribution channel in several European countries, such as Germany, France, Italy, Spain, U.K., Russia and Rest of Europe is included in this chapter.
Chapter 9 – APEC Rosacea Therapeutics Market Analysis 2013-2017 & Forecast 2018-2026
Growth prospects of Rosacea therapeutics in the APEC region that are the prime subject of assessment of the APEC Rosacea therapeutics market in this chapter. Readers can find thorough information about the growth parameters of the APEC Rosacea therapeutics market during the period 2018-2026.
Chapter 10 – MEA Rosacea Therapeutics Market Analysis 2013-2017 & Forecast 2018-2026
This chapter provides information on how the Rosacea therapeutics market will grow in the MEA region during the period 2013-2026.
Chapter 11 – Competition Landscape, Company Share and Company Profiles
In this chapter, readers can find a comprehensive list of all the leading stakeholders in the Rosacea therapeutics market along with detailed information about each company, including company overview, revenue shares, strategic overview, and recent company developments. Market players featured in the report include Pfizer Inc., Teva Pharmaceutical Industries Ltd., Mylan N.V., Bayer AG, Janssen Pharmaceuticals, Inc.
Chapter 12 – Assumptions and Acronyms
This chapter includes a list of acronyms and assumptions that provide a base to the information and statistics included in the report.
Chapter 13 – Research Methodology
This chapter helps readers to understand the research methodology followed to obtain various conclusions, important qualitative information, and quantitative information about the Rosacea therapeutics market.
Global Market Study on Rosacea Therapeutics: Emergence of Laser Therapy and Dermabrasion Trending the Global MarketBuy Now
Custom Market Research Services
xploreMR offers custom market reserch services that help clients to get information on their business scenario required where syndicated solutions are not enough
Why Choose XploreMR
Our analysts go above and beyond to answer your specific queries. We are with you throughout the entire journey – from initial discussion to post-purchase.
Country-wise Analysis & Forecasting
As we track markets at country-level, we are able to offer hard-to-find market intelligence in both developed and emerging countries.
High Quality At Competitive Pricing
We believe high quality market research shouldn’t be out of reach for businesses. Our competitively-priced market research reports ensure businesses of all sizes have access to quality information
Global Market Study on Alexandrite Laser Treatment: Rising Preference for Non-invasive Aesthetic Treatments to Catalyze Market Expansion
Alexandrite Laser Treatment Market - Scope of Report A latest publication by XploreMR on the global alexandrite laser treatment market evaluates the opportunities and current market landsca ...
Global Market Study on Alopecia Treatment: High Demand for Effective Hair Loss Treatment Dugs with Minimal Side-effects Aiding Market Growth
Alopecia Treatment Market - Scope of the Report XploreMR recently published a market study on the global alopecia treatment market. The study provides detailed assessment of key market dynamics, ...